✦ LIBER ✦

Enhanced skin toxicity associated with the combination of clofarabine plus cytarabine for the treatment of acute leukemia

✍ Scribed by Zhang, Bingnan; Bolognia, Jean; Marks, Peter; Podoltsev, Nikolai

Book ID: 125344335
Publisher: Springer
Year: 2014
Tongue: English
Weight: 328 KB
Volume: 74
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-014-2504-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clofarabine : In search of combinations

Clofarabine : In search of combinations for the treatment of patients with high-risk acute myeloid leukemia

✍ Pellegrino Musto; Felicetto Ferrara 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Clofarabine Plus Cytarabine Compared Wit

Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial

✍ Faderl, S.; Wetzler, M.; Rizzieri, D.; Schiller, G.; Jagasia, M.; Stuart, R.; Ga 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 157 KB

Sorafenib As Monotherapy or in Associati

Sorafenib As Monotherapy or in Association With Cytarabine and Clofarabine for the Treatment of Relapsed/Refractory FLT3 ITD-Positive Advanced Acute Myeloid Leukemia

✍ Fontanelli, Giulia; Rocco, Melania; Caracciolo, Francesco; Benedetti, Edoardo; B 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 283 KB

A randomized study of mitoxantrone plus

A randomized study of mitoxantrone plus cytarabine versus daunomycin plus cytarabine in the treatment of previously untreated adult patients with acute nonlymphocytic leukemia

✍ S. Pavlovsky; J. Gonzalez Llaven; M. A. Garcia Martinez; P. Sobrevilla; M. Eppin 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 444 KB

All-transretinoic acid plus low doses of

All-transretinoic acid plus low doses of cytarabine for the treatment of “poor-risk” acute myeloid leukemias

✍ A. Venditti; R. Stasi; M. Masi; G. Del Poeta; C. Cox; A. Franchi; D. Piccioni; A 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 163 KB

Idarubicin in combination with intermedi

Idarubicin in combination with intermediate-dose cytarabine in the treatment of refractory or relapsed acute leukemias

✍ Angelo M. Carella; Ester Pungolino; Gabriella Piatti; Eugenia Gaozza; Sandro Nat 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB